|
||||||||||||
| ||||||||||||
See Related: |
Vitamin A Intake and Hip Fractures Among Postmenopausal Women Context Ingestion of toxic amounts of vitamin A affects bone remodeling and can have adverse skeletal effects in animals. The possibility has been raised that long-term high vitamin A intake could contribute to fracture risk in humans. Objective To assess the relationship between high vitamin A intake from foods and supplements and risk of hip fracture among postmenopausal women. Design Prospective analysis begun in 1980 with 18 years of follow-up within the Nurses' Health Study. Setting General community of registered nurses within 11 US states. Participants A total of 72 337 postmenopausal women aged 34 to 77 years. Main Outcome Measures Incident hip fractures resulting from low or moderate trauma, analyzed by quintiles of vitamin A intake and by use of multivitamins and vitamin A supplements, assessed at baseline and updated during follow-up. Results From 1980 to 1998, 603 incident hip fractures
resulting from low or moderate trauma were identified. After controlling
for confounding factors, women in the highest quintile of total vitamin A
intake ( Conclusions Long-term intake of a diet high in retinol may promote the development of osteoporotic hip fractures in women. The amounts of retinol in fortified foods and vitamin supplements may need to be reassessed. JAMA. 2002;287:47-54 Ingestion of toxic amounts of vitamin A has long been known to have adverse skeletal effects.1, 2 In animals, retinoic acid suppresses osteoblast activity,3 stimulates osteoclast formation,4 and antagonizes the ability of vitamin D to maintain normal serum calcium levels,5 all of which may contribute to the accelerated bone resorption and fractures observed with hypervitaminosis A.6 In humans, long-term ingestion of high amounts of vitamin A can lead to hypercalcemia and bone abnormalities.7 In addition, lower bone mass8 and decreased biochemical markers for bone turnover9 have been observed in patients treated with retinoids for skin diseases. These documented effects on bone from acute toxic exposure or chronic high-dose intake of vitamin A have led to speculation that long-term consumption of diets high in vitamin A may contribute to osteoporosis and hip fractures. In Sweden, where both vitamin A intake and hip fracture incidence are high, Melhus et al10 reported a 10% reduction in femoral bone mineral density and a doubling of the risk of hip fracture among women consuming more than 1500 µg/d of retinol compared with women who consumed less than 500 µg/d. However, in contrast with these findings, there was no evidence that vitamin A intake was associated with radial bone loss among postmenopausal women participating in a 4-year calcium supplementation trial,11 and neither serum retinol level nor vitamin A supplement use was related to either radial bone mass or fracture history among a sample of postmenopausal women in Iowa.12 To further investigate this issue, we conducted an 18-year prospective analysis of vitamin A intake and hip fractures among postmenopausal women in the Nurses' Health Study. We anticipated an increased risk of hip fracture among the women with the highest retinol consumption from foods or supplements, but no significant increase with higher carotenoid intakes since long-term supplementation with beta carotene does not increase serum retinol concentrations.13 METHODSThe Nurses' Health Study (NHS) began in 1976 when 121 700 female registered nurses aged 30 to 55 years and living in 1 of 11 US states responded to the initial mailed questionnaire. A medical history and information on behaviors and lifestyle were collected at that time. Subsequent follow-up questionnaires have been mailed every 2 years to update data, collect information on new risk factors of interest, and identify incident diseases. Dietary data were first collected in 1980. At least 90% of the cohort has responded in each 2-year follow-up cycle. Deaths are confirmed through the National Death Index. Approximately 98% of the cohort is white. Only postmenopausal women (via natural or surgical menopause) who responded to the dietary questionnaire in 1980 were included in this analysis. Women entered analysis in 1980 or in the follow-up cycle in which they first reported being postmenopausal. We excluded women at baseline with a previous hip fracture or a diagnosis of cancer, heart disease, stroke, or osteoporosis because these conditions could have caused a change in usual dietary habits. A total of 72 337 women ranging in age from 34 to 77 years contributed to this analysis. Hip Fractures Dietary Assessment Exposure data were derived for total vitamin A, retinol, and provitamin A carotenoids, including beta carotene, alpha carotene, and beta cryptoxanthin. All measures were adjusted for total energy intake using regression analysis.17 In these analyses, the vitamin A, retinol, and carotenoid intakes were cumulatively updated during follow-up. That is, at the beginning of each 2-year follow-up cycle, the nutrient intake was calculated as the mean of all reported intakes up to that time. For example, at the beginning of analysis in 1980, vitamin A intake was simply the value from the 1980 FFQ; in the 2-year cycle beginning in 1994, vitamin A intake was calculated as the mean of the values from the 1980, 1984, 1986, 1990, and 1994 FFQs. Statistical models also included the following dietary variables that are potential confounders of the association between vitamin A and hip fractures: calcium, vitamin D, vitamin K, protein, alcohol, and caffeine. As was done for the vitamin A and carotenoid measures, the covariate nutrient intakes that are correlated with total energy intake (all except alcohol and caffeine) were adjusted for total energy, and all were cumulatively updated during follow-up. The food and nutrient assessments from the FFQ have been validated in several substudies within the NHS cohort. In a comparison of the 1986 FFQ with two 1-week diet records among 191 women, correlation coefficients were 0.79 for total vitamin A from food only and 0.59 for retinol from food only.18 In another substudy,19 the correlation between beta carotene intake from the 1986 FFQ and plasma beta carotene levels among 186 women was 0.31 (P<.05). Other Covariates Statistical Analysis RESULTSTable 1 outlines the changes in vitamin A, retinol, and beta carotene intakes and in consumption patterns of supplements and foods that were major contributors to vitamin A intake in the NHS cohort during follow-up. Between 1980 and 1994, mean total retinol intake decreased from 1378 to 1114 µg/d and mean total beta carotene intake increased from 4278 to 5908 µg/d. Multivitamins were the primary contributors to total retinol (35%-43% of intake), and carrots contributed the most to total beta carotene intake (30%-41% of intake). Liver was the primary food source of retinol, although its contribution declined between 1980 and 1994 while the percentages from milk and breakfast cereals increased. In 1994, mean retinol intake limited to food sources was 546 µg/d, similar to the 527 µg/d reported for women aged 51 to 70 years in the 1988-1994 Third National Health and Nutrition Examination Survey (NHANES III).20 Beta carotene intake from food in the NHS cohort remained fairly stable during follow-up at about 4500 µg/d, much higher than the mean intake of 2665 µg/d reported from NHANES III. Multivitamins were used by 34% of the cohort in 1980; this increased to 53% by 1996. Vitamin A supplement use remained between 3% and 5% during the follow-up period. No more than 3% of the cohort used beta carotene supplements between 1984 and 1992. This increased to 10% in 1994. The recommended dietary allowance for vitamin A has recently been set at 700 µg/d for women, with a tolerable upper limit of 3000 µg/d.20 During follow-up, about 14% of NHS women had intakes below the recommended dietary allowance while 21% consumed more than the tolerable upper limit. Table 2 shows the age-standardized characteristics of the study population by quintiles of vitamin A intake. Women with higher vitamin A intakes, whether from food only or from food plus supplements, were less likely to smoke and were more physically active. Those who consumed more vitamin A from food had diets higher in calcium, protein, vitamin D, and vitamin K and somewhat lower in alcohol. They were also more likely to take a multivitamin, vitamin A, or beta carotene supplement. In the highest quintile of vitamin A intake from food plus supplements, 67% of the women were taking a multivitamin, compared with only 17% in the lowest quintile. Among the postmenopausal women in the study population from 1980 to 1998, we identified 603 cases of nontraumatic hip fractures. The mean age at fracture was 64 years. Associations between hip fractures and cumulatively updated intakes of vitamin A, retinol, and beta carotene are shown in Table 3. Because of a lower prevalence of other risk factors among women with higher vitamin A intake, associations between vitamin A and risk of hip fracture were substantially stronger after controlling for these in multivariate analyses. For women in the highest quintile of vitamin A intake from food plus supplements compared with those in the lowest quintile, the multivariate RR of hip fracture was 1.48 (95% confidence interval [CI], 1.05-2.07) and the linear trend was significant (P = .003). For retinol from food plus supplements, the increase in risk was even greater (RR, 1.89; 95% CI, 1.33-2.68; P for trend <.001). For beta carotene, we observed only a weak and nonsignificant increase in risk of hip fracture (RR, 1.22; 95% CI, 0.90-1.66; P for trend = .10). To compare our results with those from Melhus et al,10 we reanalyzed our data comparing women with retinol intakes of more than 1500 µg/d with women consuming less than 500 µg/d. We found an RR of 1.64 (95% CI, 1.14-2.35) in the high-intake category, similar to the odds ratio of 1.54 (95% CI, 1.06-2.24) reported by Melhus et al from their model, which, like ours, controlled for calcium intake. To assess risk of fracture from food sources only, we excluded women from further follow-up when they reported taking a multivitamin or a specific vitamin A or beta carotene supplement. These intakes from food do, however, include vitamin A fortification of milk, margarine, and breakfast cereals. Relative risks were elevated in the highest quintiles of vitamin A intake from food (RR, 1.82; 95% CI, 0.97-3.40; P for trend = .24) and retinol from food (RR, 1.69; 95% CI, 1.05-2.74; P for trend = .05), similar to the results we observed for intakes from food plus supplements, despite the fact that the cut points for the highest quintiles in the food analyses were lower than those used in the analyses that included supplements. Beta carotene from food showed a weak and nonsignificant positive association with fracture risk. Although beta carotene is the primary dietary carotenoid with provitamin A activity, we examined intakes of alpha carotene and beta cryptoxanthin and found no appreciable increase in risk of hip fracture with higher intakes of either of these carotenoids (data available on request from the authors). Consumption of liver and carrots, the major food sources of retinol and beta carotene, respectively, in this population, confirmed the results we observed in the nutrient analyses. Women who consumed liver 1 or more times per week had an elevated although nonsignificant RR of 1.69 (95% CI, 0.95-3.04) for hip fracture compared with women who never consumed liver. For women who consumed carrots 1 or more times per day compared with less than once per week, the RR was 1.05 (95% CI, 0.61-1.82). Using intake as a continuous variable, for every additional 500-µg/d increase in retinol intake, hip fracture risk increased significantly: 15% (95% CI, 8%-22%) for retinol from food plus supplements and 33% (95% CI, 9%-64%) for retinol from food only. For a 2000-µg daily increase in beta carotene, the increase in fracture risk was not statistically significant: 7% (95% CI, -1% to 15%) for total beta carotene and 2% (95% CI, -10% to 17%) for beta carotene from food only. Results from analyses using only the 1980 baseline diet to characterize nutrient intakes over the 18 years of follow-up were weaker than the results from the Table 3 analyses in which nutrient intakes were cumulatively updated over time. In these baseline analyses, the RRs for hip fracture in the highest quintiles of intake were 1.10 (95% CI, 0.82-1.47) for baseline vitamin A from food plus supplements and 1.17 (95% CI, 0.87-1.58) for baseline retinol from food plus supplements. To examine the relative contributions of total retinol and beta
carotene to the risk of hip fractures, we put both nutrient intakes in the
same multivariate model. Results were similar to those reported from
separate models (data available on request from the authors). We also
examined the association between beta carotene and hip fractures within
strata of retinol intake. Since absorption of beta carotene and its
conversion to retinol is greater when retinol intake is low, any elevated
risk of hip fracture with higher beta carotene intake might be seen most
clearly among women with the lowest retinol intakes. However, among women
in the lowest tertile of retinol intake from food plus supplements, those
in the highest compared with the lowest quintile of beta carotene intake
from food plus supplements had an RR of hip fracture of 0.94 (95% CI,
0.53-1.68). We performed other stratified analyses by intakes of calcium
(<800 vs We also examined intakes of vitamin A, retinol, and beta carotene stratified by postmenopausal hormone use. For retinol from food plus supplements, the risk of hip fracture was significantly elevated only among the women not using postmenopausal hormones (Table 4). In comparison to the reference group of current hormone users in the lowest quintile of retinol intake, the RRs in the highest retinol quintiles were 2.52 (95% CI, 1.48-4.31) among women not using postmenopausal hormones and only 1.26 (95% CI, 0.68-2.33) among current hormone users. Unlike retinol, higher beta carotene intake did not confer a greater risk of hip fracture among the women not using postmenopausal hormones (data available on request from the authors). Associations between hip fractures and use of multivitamins, vitamin A supplements, and beta carotene supplements are shown in Table 5. Risk of hip fracture was elevated with current use of either vitamin A supplements (RR, 1.40; 95% CI, 0.99-1.99) or multivitamins (RR, 1.32; 95% CI, 1.04-1.67), although we did not observe a linear increase in risk with longer duration of use for either one. Risk also was elevated among past users, though time since last use was low: 41% of past multivitamin users and 31% of past vitamin A supplement users had quit within the 2-year period since the previous questionnaire. Multivitamins are a source of vitamin D and calcium as well as retinol; therefore, these analyses were controlled for total vitamin D and calcium intakes. Risk of hip fracture was even greater for current vitamin A supplements users (RR, 1.75; 95% CI, 1.09-2.80) and multivitamin users (RR, 1.59; 95% CI, 1.12-2.26) among women with low intakes of retinol from food sources (<600 µg/d). Use of beta carotene supplements did not confer any increase in risk of hip fractures. COMMENTIn this prospective cohort study of postmenopausal women, the risk of hip fracture was almost doubled among women with retinol intakes of about 2000 µg/d or more compared with those with intakes of less than about 500 µg/d. Current use of vitamin A supplements alone was associated with a 40% (nonsignificant) increase in risk. In contrast with retinol, higher intakes of beta carotene did not significantly increase the risk of hip fracture. Our results are consistent with those reported by Melhus et al in Sweden.10 In that nested case-control study with 247 hip fracture cases among women aged 40 to 76 years, the risk of fracture was doubled for a retinol intake of greater than 1500 µg/d compared with an intake of less than 500 µg/d, and risk was found to increase linearly (P = .006). With calcium in the model, the odds ratio was reduced to 1.54 but remained statistically significant. Using the same comparison groups, we found a similar RR of 1.64. Among the postmenopausal women in the NHS cohort, we observed a strong positive association between retinol intake and hip fractures only among those not currently using postmenopausal hormones. We had no prior hypothesis for this finding; therefore, it needs to be examined in other studies. Due to the high rate of absorption and the large storage capacity for retinol in the human body,21 vitamin A toxicity can result from acute ingestion of a very high dose, generally more than 100 000 IU,22 or from repeated exposure for several weeks or months to lesser dosages (eg, between 25 000 and 50 000 IU/d)6 (1 IU = 0.3 µg of retinol). Vitamin A toxicity has not been observed with excessive intakes of beta carotene,23 presumably because of limitations on its absorption and conversion to retinol.24 Excess vitamin A is known to have teratogenic effects on bone growth in mice25, 26 and is likely to affect human fetal bone development as well.27 In growing animals, hypervitaminosis A can produce bone fractures28-30 and other skeletal anomalies.31, 32 Isolated cases of hypervitaminosis A in humans were associated with bone pain, hypercalcemia, and increased bone resorption.6 Also, patients undergoing long courses of treatment with retinoids, such as isotretinoin and etretinate for skin conditions, have experienced progressive calcification of ligaments, modeling abnormalities of long bones, and osteoporosis.33, 34 Direct effects of vitamin A on bone osteoclasts and osteoblasts have been demonstrated in vitro that increase bone resorption and decrease formation.3, 4, 29, 35 If this mechanism occurs in vivo, long-term exposure to high vitamin A amounts could plausibly lead to low bone density and fractures. This may be exacerbated in older adults with diminished capacity to clear high levels of ingested retinol.36 A deleterious effect of vitamin A on bone may also operate through its antagonistic relationship with vitamin D. In a recent study in humans, a vitamin A dose corresponding to about 1 serving of liver was shown to severely diminish the ability of vitamin D to increase intestinal calcium absorption.37 Melhus et al10 noted that hip fracture incidence in Europe is highest in Sweden and Norway, countries that also have the highest intakes of vitamin A, primarily from fish oils and dairy foods. In the United States, high consumption is also common and easily attainable. Due to the loss of vitamin A with the removal of fat, skim and low-fat milk are fortified to at least 350 µg/c (1500 µg/L). One tbsp (15 mL) of fortified margarine also contains about 150 µg of vitamin A and breakfast cereals are often fortified with up to 375 µg per serving. In addition, multivitamins may contain 1500 µg of retinol per tablet, although in more recent formulations part of the vitamin A content may be contributed by beta carotene. It is also possible to purchase vitamin A supplements in doses of 3000 µg. Supplements contribute significantly to vitamin A intake in the United States. In a sample of adult women in NHANES III, the mean intake of vitamin A from supplements was 1338 µg/d,20 and in the NHS cohort, more than 20% of the vitamin A in the diet was provided by multivitamins and about 5% came from vitamin A supplements. However, multivitamins contain other essential nutrients and have been associated with lower risk of coronary disease,38 colon cancer,39 and breast cancer40 in this same cohort. Also, the findings from this study do not imply that supplementation with vitamin A should be discontinued when used for conditions such as retinitis pigmentosa, for which benefits have been documented,41 although monitoring of bone health may be appropriate. This study was conducted in a mostly white population of women and results may not be generalizable to other racial/ethnic groups. Results are also limited to self-reported hip fractures with no further identification of exact fracture site. The strengths of this study are the 90% follow-up rate over 18 years and the repeated assessment of diet and supplement use. Results were greatly attenuated when only the initial reported diet was used for analyses because of real changes in diet over time and random error from a single measure, which is reduced when dietary intakes are cumulatively averaged with each new assessment. Our findings provide further evidence that chronic intake of excessive vitamin A, particularly from retinol, may contribute to the development of osteoporotic hip fractures in women. The amounts of retinol in fortified foods and vitamin supplements may need to be reassessed since these add significantly to total retinol consumption in the United States. Author/Article Information Author Affiliations: Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School (Drs Feskanich, Willett, and Colditz), and Departments of Nutrition (Dr Willett) and Epidemiology (Drs Willett and Colditz), Harvard School of Public Health, Boston, Mass; and Roche Vitamins Inc, Human Nutrition Research, Parsipanny, NJ (Dr Singh). Corresponding Author and Reprints: Diane Feskanich, ScD, Channing Laboratory, 181 Longwood Ave, Boston, MA 02115 (e-mail: diane.feskanich@channing.harvard.edu). Author Contributions: Study concept and design: Feskanich, Singh, Willett, Colditz. Acquisition of data: Feskanich, Willett. Analysis and interpretation of data: Feskanich, Willett, Colditz. Drafting of the manuscript: Feskanich, Willett. Critical revision of the manuscript for important intellectual content: Feskanich, Singh, Willett, Colditz. Statistical expertise: Feskanich, Willett. Obtained funding: Singh, Willett. Administrative, technical, or material support: Colditz. Study supervision: Colditz. Funding/Support: This research was supported by grant CA87969 from the National Institutes of Health as well as a grant from Hoffmann-La Roche Inc. In addition, for activities related to the Nurses' Health Studies, we have received modest additional resources at various times and for varying periods since January 1, 1993, from the Alcoholic Beverage Medical Research Foundation, the American Cancer Society, Amgen, the California Prune Board, the Centers for Disease Control and Prevention, the Ellison Medical Foundation, the Florida Citrus Growers, the Glaucoma Medical Research Foundation, Kellogg's, Lederle, the Massachusetts Department of Public Health, Mission Pharmacal, the National Dairy Council, Rhone Poulenc Rorer, the Robert Wood Johnson Foundation, Roche, Sandoz, the US Department of Defense, the US Department of Agriculture, the Wallace Genetics Fund, Wyeth-Ayerst, and private contributions. REFERENCES1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. |
||||||||
© 2002 American Medical Association. All rights reserved. |